Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population

Cancer

Volumn 115, Issue 18, 2009, Pages 4167-4175

  Huang, Bin ^a   Carloss, Harry ^b   Wyatt, Stephen W ^c   Riley, Elizabeth ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Western Kentucky Hematology and Oncology Group   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Female; Hormone replacement therapy; Lung cancer; Smoking; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH INSURANCE; HORMONE SUBSTITUTION; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIMARY TUMOR; PRIORITY JOURNAL; RURAL POPULATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; POSTMENOPAUSE; RETROSPECTIVE STUDIES; RURAL POPULATION; SMOKING;

EID: 70149090142     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24475     Document Type: Article

References (34)

1. American Cancer Society. Cancer Facts and Figures 2008. Available at: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf Accessed August 8, 2008.
2. Kentucky Cancer Registry. Available at: URL: http://www.kcr.uky.edu/ Accessed August 8, 2008.
3. Patel J, Bach P, Kris M. Lung cancer in US women, a contemporary epidemic. JAMA. 2004;291:1763-1768. (Pubitemid 38489898)
4. Patel J. Lung cancer in women. J Clin Oncol. 2005;23:3212-3218.
5. Risch HA, Howe GR, Jain M, et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol. 1993;138:281-293. (Pubitemid 23263599)
6. Harris RE, Zang EA, Anderson JI, et al. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol. 1993;22:592-599. (Pubitemid 23247558)
7. Gasperino J, Rom WN. Gender and lung cancer. Clin Lung Cancer. 2004;5:353-359.
8. Wakelee HA, Chang ET, Gomez SL, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007;25:472-478. (Pubitemid 350002951)
9. International Early Lung Cancer Action Program Investigators. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA. 2006;296:180-184.
10. Fu JB, Ying Kau T, Severson RK, et al. Lung cancer in women: analysis of the national surveillance, epidemiology, and end results database. Chest. 2005;127:768-777. (Pubitemid 40775504)
11. Omoto Y, Kobayashi Y, Nishida K, et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancer. Biochem Biophys Res Commun. 1996;285:340-347.
12. Liu Y, Inoue M, Sobue T, Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middleaged never smoking Japanese women: a large-scale population- based cohort study. Int J Cancer. 2005;117:662-666. (Pubitemid 41504556)
13. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer. 2007;120:2214-2220. (Pubitemid 46555861)
14. Elliott AM, Hannaford PC. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception. 2006;73:331-335.
15. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE. Hormonal factors and risk of lung cancer among women? Int J Epidemiol. 2003;32:263-271.
16. Olsson H, Bladstrom A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol. 2003;102:565-570.
17. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004;10:113-123. (Pubitemid 38114169)
18. Chen KY, Hsiao CF, Chang GC, et al. Hormone replacement therapy and lung cancer risk in Chinese. Cancer. 2007;110:1768-1775. (Pubitemid 47557301)
19. Alexiou C, Onyeaka CVP, Beggs D, et al. Do women live longer after lung resection for carcinoma? Eur J Cardiothorac Surg. 2002;21:319-325.
20. Visbal AL, Williams BA, Nichols FC, et al. Gender differences in nonsmall cell cancer survivors: an analysis of 4618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004;78:209-215.
21. Tsao AS, Liu D, Lee JJ, et al. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer. 2006;106:2428-2436. (Pubitemid 43787667)
22. Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med. 2006;144:381-389. (Pubitemid 46768159)
23. Ettinger B, Friedman GD, Bush T, et al. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996;87:6-12. (Pubitemid 26015941)
24. Blackman JA, Coogan PF, Rosenberg L, et al. Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf. 2002;11:561-567. (Pubitemid 35345406)
25. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol. 2006;24:59-63. (Pubitemid 46630494)
26. U.S. Department of Agriculture ERS. Measuring rurality: rural-urban continuum codes. Available at: http://www.ers.usda.gov/Briefing/Rurality/ RuralUrbCon/ Accessed August 8, 2008.
27. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
28. Stabile LP, Davis AL, Gubish CT, et al. Human nonsmall cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002;62:2141-2150.
29. Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11:7280-7287. (Pubitemid 41507685)
30. Hershberger PA, Vasquez AC, Kanterwicz B, et al. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005;65:1598-1605. (Pubitemid 40270190)
31. Stabile LP, Lyker JS, Gubish CT, et al. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res. 2005;65:1459-1470. (Pubitemid 40270175)
32. Ishibashi H, Suzuki T, Suzuki S, et al. Progesterone receptor in non-small cell lung cancer: a potent prognostic factor and possible target for endocrine therapy. Cancer Res. 2005;65:6450-6458. (Pubitemid 40994434)
33. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003;289:3243-3253. (Pubitemid 37430077)
34. Schwartz AG, Wenzlaff AS, Prysak GM, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol. 2007;25:5785-5792.